يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"and Proteins::Proteins::Recombinant Proteins::Recombinant Fusion Proteins"', وقت الاستعلام: 0.64s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Benitez Hidalgo O, Martinez Garcia MF, Gironella Mesa M, Bosch Albareda F Experimental Hematology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Bescos Cabestre A Servei de Neurocirurgia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Juarez Gimenez JC Servei de Farmàcia Hospitalària, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical Case Reports;10(5); https://doi.org/10.1002/ccr3.5848Test; Benitez Hidalgo O, Martinez Garcia MF, Bescos Cabestre A, Juarez Gimenez JC, Gironella Mesa M, Bosch Albareda F. Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management. Clin Case Reports. 2022 May;10(5):e05848.; https://hdl.handle.net/11351/8056Test; 000798984900001

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Muro K Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan. Salinardi T, Singh AR Global Medical Oncology, Sanofi, Boston, MA 02142, USA. Macarulla T Grup de Tumors gastrointestinals, Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cancers;12; https://doi.org/10.3390/cancers12040844Test; Muro K, Salinardi T, Singh AR, Macarulla T. Safety of Aflibercept in Metastatic Colorectal Cancer: A Literature Review and Expert Perspective on Clinical and Real-World Data. Cancers. 2020 Mar 31;12:844.; https://hdl.handle.net/11351/6333Test; 000535587400073

  3. 3

    المساهمون: Institut Català de la Salut, [Benitez Hidalgo O, Martinez Garcia MF, Gironella Mesa M, Bosch Albareda F] Experimental Hematology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Bescos Cabestre A] Servei de Neurocirurgia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Juarez Gimenez JC] Servei de Farmàcia Hospitalària, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  4. 4

    المساهمون: Institut Català de la Salut, [Muro K] Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan. [Salinardi T, Singh AR] Global Medical Oncology, Sanofi, Boston, MA 02142, USA. [Macarulla T] Grup de Tumors gastrointestinals, Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Cancers
    Cancers, Vol 12, Iss 844, p 844 (2020)

    وصف الملف: application/pdf

  5. 5

    المساهمون: [Alcaide,J, Rueda,A] Oncology Department, Costa del Sol Hospital, Marbella, Málaga, Spain. [Delgado,M, Legerén,M, Jurado,JM, Blancas,I, Sánchez,MJ, García,JL] Oncology Department, San Cecilio Clinical Hospital, Granada, Andalucía, Spain. [Pereda,T, López,J] Pathology Department, Costa del Sol Hospital, Marbella, Málaga, Spain. [Garrido,M] Pharmacy and Nutrition Department, Costa del Sol Hospital, Marbella, Málaga, Spain., [Alcaide, Julia] Costa Sol Hosp, Dept Oncol, Malaga 29603, Spain, [Rueda, Antonio] Costa Sol Hosp, Dept Oncol, Malaga 29603, Spain, [Delgado, Mayte] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Legeren, Marta] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Jurado, Jose Miguel] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Blancas, Isabel] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Sanchez, Maria J.] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Garcia, Jose L.] San Cecilio Clin Hosp, Dept Oncol, Dr Oloriz Ave, Granada 18014, Andalucia, Spain, [Pereda, Teresa] Costa Sol Hosp, Dept Pathol, Malaga 29603, Spain, [Lopez, Jorge] Costa Sol Hosp, Dept Pathol, Malaga 29603, Spain, [Garrido, Margarita] Costa Sol Hosp, Pharm & Nutr Dept, Malaga 29603, Spain, Sanofi Spain (Barcelona, Spain)

    المصدر: Oncology Letters

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Colorectal cancer, Leucovorin, Chemicals and Drugs::Heterocyclic Compounds::Alkaloids::Camptothecin [Medical Subject Headings], Ras mutations, Targeted therapy, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], angiogenesis, 1st progression, 0302 clinical medicine, Neoplasias colorrectales, Camptotecina, Ensayos de Uso compasivo, Aflibercept, Proteínas recombinantes de fusión, Metastatic colorectal cancer, Chemicals and Drugs::Organic Chemicals::Organometallic Compounds::Organoplatinum Compounds [Medical Subject Headings], metastatic colorectal cancer, aflibercept, Articles, targeted therapy, VEGF, Humanos, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Recombinant Proteins::Recombinant Fusion Proteins [Medical Subject Headings], Proteinuria, 030220 oncology & carcinogenesis, Chemicals and Drugs::Macromolecular Substances::Polymers::Polyesters [Medical Subject Headings], Combination, Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Leukocyte Disorders::Leukopenia::Agranulocytosis::Neutropenia [Medical Subject Headings], Fluorouracil, Compuestos organoplatinos, medicine.drug, medicine.medical_specialty, Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation [Medical Subject Headings], Bevacizumab, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Therapies, Investigational::Compassionate Use Trials [Medical Subject Headings], Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases::Receptors, Vascular Endothelial Growth Factor [Medical Subject Headings], Guidelines, Neutropenia, Irinotecan, Association, Xenograft models, 03 medical and health sciences, VEGFR, Diseases::Cardiovascular Diseases::Vascular Diseases::Hypertension [Medical Subject Headings], Internal medicine, Hipertensión, medicine, Chemotherapy, Supervivencia sin enfermedad, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Disease-Free Survival [Medical Subject Headings], Mutación, business.industry, Diseases::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms [Medical Subject Headings], Receptores de Factores de crecimiento endotelial vascular, medicine.disease, Oxaliplatin, Surgery, Clinical trial, Regimen, Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Urological Manifestations::Proteinuria [Medical Subject Headings], 030104 developmental biology, Angiogenesis, Poliésteres, business

    وصف الملف: application/pdf